In bladder cancer, SHCBP1 augments EGF-induced invasive behavior by associating with RACGAP1 and restricting the GTP hydrolysis activity of RAC1, a critical regulator of actin cytoskeleton dynamics and cell motility [23]. Here, SHCBP1 is linked to urinary bladder cancer.